HomeRAPP • NASDAQ
add
Rapport Therapeutics Inc
Previous close
$28.67
Day range
$27.37 - $29.84
Year range
$7.73 - $42.27
Market cap
1.33B USD
Avg Volume
334.49K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 38.51M | 63.72% |
Net income | -33.76M | -68.98% |
Net profit margin | — | — |
Earnings per share | -0.72 | -26.32% |
EBITDA | -38.24M | -64.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 490.54M | 60.68% |
Total assets | 512.43M | 62.71% |
Total liabilities | 27.78M | 192.22% |
Total equity | 484.65M | — |
Shares outstanding | 47.79M | — |
Price to book | 2.82 | — |
Return on assets | -18.38% | — |
Return on capital | -18.88% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -33.76M | -68.98% |
Cash from operations | -24.70M | -70.99% |
Cash from investing | -174.32M | -645.96% |
Cash from financing | 311.00K | 4,342.86% |
Net change in cash | -198.71M | -1,236.09% |
Free cash flow | -14.21M | -56.99% |
About
Founded
2022
Headquarters
Website
Employees
84
